Singapore markets closed

Vir Biotechnology, Inc. (VIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.68-0.08 (-0.74%)
At close: 04:00PM EDT
10.68 0.00 (0.00%)
After hours: 05:39PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close10.76
Open10.79
Bid11.40 x 900
Ask11.41 x 800
Day's range10.59 - 10.80
52-week range7.72 - 27.48
Volume875,824
Avg. volume1,116,216
Market cap1.442B
Beta (5Y monthly)0.42
PE ratio (TTM)N/A
EPS (TTM)-4.59
Earnings date02 May 2024 - 06 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est32.29
  • Business Wire

    Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule

    SAN FRANCISCO, March 05, 2024--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that its Phase 2 SOLSTICE clinical trial evaluating the safety, tolerability and efficacy of tobevibart and elebsiran for the treatment of people living with chronic hepatitis delta (CHD) virus has completed enrollment of its current cohorts one month earlier than anticipated. This includes over 60 participants in two additional cohorts – one evaluating tobevibart given every 2 weeks and the other evaluating the

  • Thomson Reuters StreetEvents

    Q4 2023 Vir Biotechnology Inc Earnings Call

    Q4 2023 Vir Biotechnology Inc Earnings Call

  • Insider Monkey

    Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Earnings Call Transcript

    Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Earnings Call Transcript February 22, 2024 Vir Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.86, expectations were $-1.14. Vir Biotechnology, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello. Welcome to Vir […]